Standard Biotools (LAB) FCF Margin Growth (3y) (2013 - 2026)
Standard Biotools (LAB) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.02 Bn | 179.73 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 132.07 Bn | 129.19 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 111.38 Bn | 102.16 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 68.98 Bn | 67.53 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn | -2,196.00 |
| 6 | Dexcom | 28.91 Bn | 27.80 Bn | 750.30 Mn | 2,679.00 |
| 7 | GE HealthCare Technologies | 28.83 Bn | 26.55 Bn | 1.98 Bn | -472.00 |
| 8 | Smith & Nephew | 28.10 Bn | 27.52 Bn | - | - |
| 9 | Koninklijke Philips | 24.30 Bn | 21.26 Bn | 2.01 Bn | 11.00 |
| 10 | Standard Biotools | 302.10 Mn | -153.08 Mn | 11.31 Mn | -18,407.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18,407.00 |
| Dec 31, 2025 | 6,577.00 |
| Sep 30, 2025 | -1,242.00 |
| Jun 30, 2025 | 9,211.00 |
| Mar 31, 2025 | -11,265.00 |
| Sep 30, 2024 | -9,469.00 |
| Jun 30, 2024 | -10,956.00 |
| Mar 31, 2024 | -7,845.00 |
| Dec 31, 2023 | -775.00 |
| Sep 30, 2023 | -3,617.00 |
| Jun 30, 2023 | -2,358.00 |
| Mar 31, 2023 | -1,852.00 |
| Dec 31, 2022 | -5,523.00 |
| Sep 30, 2022 | -7,865.00 |
| Jun 30, 2022 | -14,544.00 |
| Mar 31, 2022 | 564.00 |
| Sep 30, 2021 | -3,929.00 |
| Jun 30, 2021 | -4,394.00 |
| Mar 31, 2021 | 392.00 |
| Dec 31, 2020 | -3,411.00 |